SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs

Sophie Belman; Senjuti Saha; Mathew A Beale

doi:10.1038/s41579-021-00664-y

SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs

Nat Rev Microbiol. 2022 Jan;20(1):3. doi: 10.1038/s41579-021-00664-y.

Authors

Sophie Belman¹, Senjuti Saha², Mathew A Beale³

Affiliations

¹ Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
² Child Health Research Foundation, Dhaka, Bangladesh.
³ Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mathew.beale@sanger.ac.uk.

Abstract

This Genome Watch highlights how the SARS-CoV-2 pandemic laid the groundwork for continued use of real-time genomic epidemiology for public health responses in low-and-middle-income countries.

MeSH terms

Africa / epidemiology
Bangladesh / epidemiology
COVID-19 / diagnosis
COVID-19 / economics
COVID-19 / epidemiology*
COVID-19 / transmission
Developing Countries / economics
Epidemiological Monitoring
Genome, Viral*
Genomics / economics*
Genomics / instrumentation
Genomics / methods
Humans
Nanopore Sequencing / economics*
Nanopore Sequencing / instrumentation
Nanopore Sequencing / methods
Phylogeny
SARS-CoV-2 / classification
SARS-CoV-2 / genetics*
SARS-CoV-2 / isolation & purification
SARS-CoV-2 / pathogenicity